PS www.ProStocks.com
|
|
Incorporated in 1993, Syngene International Ltd is a subsidiary of Biocon Limited ("Biocon"), a global biopharmaceutical enterprise focused on delivering affordable formulations and compounds.
Headquartered in Bengaluru, Syngene International is India-based contract research organisations ("CRO"), offering a suite of integrated, end-to-end discovery and development services for novel molecular entities ("NMEs") across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. Their services in discovery and development cover multiple domains across small molecules, large molecules, antibody-drug conjugates ("ADC") and oligonucleotides.
Syngene offer customized models as per their clients requirements. These range from a full-time equivalent ("FTE") to a fee-for-service ("FFS") model, or a combination thereof. Till Dec 31, 2014, they serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014. Company's long term clients includes global healthcare organisations Bristol-Myers Squibb Co. ("BMS"), Abbott Laboratories (Singapore) Pte. Ltd. ("Abbott") and Baxter International Inc. ("Baxter").
| IPO Date | Jul 27, 2015 to Jul 29, 2015 |
| Listing Date | Aug 11, 2015 |
| Face Value | ₹10 per share |
| Price | ₹240 to ₹250 per share |
| Lot Size | 60 Shares |
| Total Issue Size | 22,000,000 shares (aggregating up to ₹550.00 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| QIB Shares Offered | 4,000,000 (25.00%) |
| NII (HNI) Shares Offered | 3,000,000 (18.75%) |
| Retail Shares Offered | 7,000,000 (43.75%) |
| Total Shares Offered | 16,000,000 |
The Syngene International IPO lot size is 60 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 60 | ₹15,000 |
| Retail (Max) | 13 | 780 | ₹195,000 |
| Lot Size Calculator | |||
| Particulars | For the year/period ended (in Rs. Million) | |||
| 31 Dec 14 | 31 Mar 14 | 31 Mar 13 | 31 Mar 12 | |
| Total Income | 6,175 | 7,077 | 5,542 | 4,182 |
| Profit After Tax (PAT) | 1,194 | 1,348 | 1,021 | 710 |
The objects of the offer are to:
1. Achieve the benefits of listing the Equity Shares on the Stock Exchanges;
2. Enhance visibility and brand image among existing and potential clients; and
3. Provide liquidity to the existing shareholders.
[Dilip Davda]
Syngene Intl Ltd - Modest investment recommended
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published here. Any reader taking decisions based on any information published here does so entirely at own risk. Author has no plans to invest in this offer.
Read detail review...The Syngene International IPO is subscribed 32.05 times on Jul 29, 2015 6:10:00 PM. The public issue subscribed 4.78 times in the retail category, 51.47 times in the QIB category, and 90.24 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 51.47 |
| NII | 90.24 |
| Retail | 4.78 |
| Others | 1.37 |
| Total | 32.05 |
| Listing Date | Aug 11, 2015 |
| BSE Script Code | 539268 |
| NSE Symbol | SYNGENE |
| ISIN | INE398R01022 |
| Final Issue Price | ₹250 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE |
|---|
| ₹250.00 |
| ₹295.00 |
| ₹295.00 |
| ₹318.20 |
| ₹310.40 |
| NSE |
|---|
| ₹250.00 |
| ₹295.00 |
| ₹295.00 |
| ₹318.50 |
| ₹310.55 |
Syngene International Ltd
Biocon SEZ Biocon Park,
Plot No 2 & 3 Bommasandra Inds,
Bengaluru - 560099, Karnataka
Phone: +91-80-28082808
Email: investor@syngeneintl.com
Website: http://www.syngeneintl.com
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: einward.ris@karvy.com
Website: https://karisma.kfintech.com/
Syngene International IPO is a main-board IPO of 22,000,000 equity shares of the face value of ₹10 aggregating up to ₹550.00 Crores. The issue is priced at ₹240 to ₹250 per share. The minimum order quantity is 60 Shares.
The IPO opens on Jul 27, 2015, and closes on Jul 29, 2015.
KFin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Syngene International IPO opens on Jul 27, 2015 and closes on Jul 29, 2015.
Syngene International IPO lot size is 60 Shares and the minimum order quantity is .
You can apply in Syngene International IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Syngene International IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Syngene International IPO allotment status.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
RHP
Top Contributor (500+ Posts, 100+ Likes)
IPO Guru (2500+ Posts, 2700+ Likes)
GIRISH KULKARNI| Link |Sep 24, 2015 1:44:08 PM